Brief: ARS Pharmaceuticals Q3 basic EPS USD -0.16
09/11/2023 21:03
Nov 9 (Reuters) - ARS Pharmaceuticals Q3 basic EPS USD -0.16. * Q3 operating expenses USD 17.978 million * Q3 net income USD -14.866 million * Q3 operating income USD -17.978 million * Q3 cash & investments USD 241.9 million
Recent news on ARS Pharmaceuticals
See all newsARS Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ARS Pharmaceuticals Q2 neffy revenue rises as epinephrine market share doubles
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle